Alick Pingbei Wang

Alick Pingbei Wang

Auto-generated profile, based on publicly available information

Alick Pingbei Wang

Department of Surgery, Division of Neurosurgery, University of Ottawa, Ottawa, Ontario, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2018 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
NLNoel Lianga
Noel Lianga
CDCarole Doré
Carole Doré
EKErin K. Kennedy
Erin K. Kennedy
EYElaine Yeh
Elaine Yeh
EWElizabeth C. Williams
Elizabeth C. Williams
ARAdam D. Rudner
Adam D. Rudner
Anaphase onset is an irreversible cell cycle transition that is triggered by the activation of the protease Separase. Separase cleaves the Mcd1 (also known as Scc1) subunit of Cohesin, a complex of proteins that physically links sister chromatids, triggering sister chromatid separation. Separase is regulated by the degradation of the anaphase inhibitor Securin which liberates Separase from inhibitory Securin/Separase complexes. In many organisms, Securin is not essential suggesting that Separase is regulated by additional mechanisms. In this work, we show that in budding yeast Cdk1 activates Separase (Esp1 in yeast) through phosphorylation to trigger anaphase onset. Esp1 activation is opposed by protein phosphatase 2A associated with its regulatory subunit Cdc55 (PP2ACdc55) and the spindle protein Slk19. Premature anaphase spindle elongation occurs when Securin (Pds1 in yeast) is inducibly degraded in cells that also contain phospho-mimetic mutations in ESP1, or deletion of CDC55 or SLK19. This striking phenotype is accompanied by advanced degradation of Mcd1, disruption of pericentric Cohesin organization and chromosome mis-segregation. Our findings suggest that PP2ACdc55 and Slk19 function redundantly with Pds1 to inhibit Esp1 within pericentric chromatin, and both Pds1 degradation and Cdk1-dependent phosphorylation of Esp1 act together to trigger anaphase onset. The fidelity of chromosome segregation is essential for the survival of cells after cell division. Mis-regulation of chromosome segregation can lead to aneuploidy which is associated with many cancers, and may initiate the formation of a cancerous cell. Chromosome segregation is triggered by the cleavage of one subunit of the Cohesin complex, a ring-shaped protein complex that topologically links replicated sister chromatids. The regulation of Cohesin cleavage relies on several redundant pathways that together decrease the chance that Cohesin is cleaved prematurely. We have identified a novel pathway that regulates Cohesin cleavage in the pericentromere, which lies between the bi-oriented sister centromeres, where microtubule attachments are built. Spatial and temporal control of Cohesin cleavage in the pericentromere is important because Cohesin creates intra-chromosomal crosslinks that protect chromosomes from the forces that pull them to poles, and at anaphase onset, the dissolution of pericentromeric cohesion triggers chromosome segregation.

1 February 2019 in World Neurosurgery
Verified
Journal Article
Closed access
HSHusain Shakil
Husain Shakil
AWAlick P. Wang
Alick P. Wang
DHDillon A. Horth
Dillon A. Horth
SNSaeda S. Nair
Saeda S. Nair
KRKesava K.V. Reddy
Kesava K.V. Reddy

1 March 2023 in Neurointervention
Verified
Journal Article
Open access
PDF file
GWGregory B. Walker
Gregory B. Walker
AWAlick P. Wang
Alick P. Wang
JHJeremiah Hadwen
Jeremiah Hadwen
UEUndrakh-Erdene Erdenebold
Undrakh-Erdene Erdenebold
RBRazmik Bebedjian
Razmik Bebedjian
RFRobert Fahed
Robert Fahed
We describe a minimally invasive endovascular approach to treat an arteriovenous fistula of the scalp. We performed a direct puncture of the lesion through the patient’s scalp for liquid embolic agent injection along with external compression of the superficial temporal artery to perform a “manual pressure-cooker technique.” The combination of these minimally invasive techniques resulted in an excellent clinical and radiographic outcome.

3 October 2022 in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Verified
Journal Article
Open access
PDF file
MKMichelle M. Kameda-Smith
Michelle M. Kameda-Smith
MRMalavan Ragulojan
Malavan Ragulojan
SHShannon Hart
Shannon Hart
TDTaylor R. Duda
Taylor R. Duda
Mark A. MacLeanMark A. MacLean
Mark A. MacLean
KRKesava Reddy
Kesava Reddy
Objective: Intracerebral abscess is a life-threatening condition for which there are no current, widely accepted neurosurgical management guidelines. The purpose of this study was to investigate Canadian practice patterns for the medical and surgical management of primary, recurrent, and multiple intracerebral abscesses. Methods: A self-administered, cross-sectional, electronic survey was distributed to active staff and resident members of the Canadian Neurosurgical Society and Canadian Neurosurgery Research Collaborative. Responses between subgroups were analyzed using the Chi-square test. Results: In total, 101 respondents (57.7%) completed the survey. The majority (60.0%) were staff neurosurgeons working in an academic, adult care setting (80%). We identified a consensus that abscesses >2.5 cm in diameter should be considered for surgical intervention. The majority of respondents were in favor of excising an intracerebral abscess over performing aspiration if located superficially in non-eloquent cortex (60.4%), located in the posterior fossa (65.4%), or causing mass effect leading to herniation (75.3%). The majority of respondents were in favor of reoperation for recurrent abscesses if measuring greater than 2.5 cm, associated with progressive neurological deterioration, the index operation was an aspiration and did not include resection of the abscess capsule, and if the recurrence occurred despite prior surgery combined with maximal antibiotic therapy. There was no consensus on the use of topical intraoperative antibiotics. Conclusion: This survey demonstrated heterogeneity in the medical and surgical management of primary, recurrent, and multiple brain abscesses among Canadian neurosurgery attending staff and residents.(1)

10 August 2022 in Operative Neurosurgery
Verified
Journal Article
Closed access
GWGregory Walker
Gregory Walker
AWAlick P. Wang
Alick P. Wang
PMPatrick Z. McVeigh
Patrick Z. McVeigh
ZIZurab Ivanishvilli
Zurab Ivanishvilli
WSWilliam Siu
William Siu
BDBrian J. Drake
Brian J. Drake
BACKGROUND: The scanning fiber endoscope (SFE) is a novel medical imaging device that has been used in various vascular beds as a form of angioscopy, as well as in tracts and duct systems for endoluminal imaging. Owing to its miniaturized form, high resolution, and flexibility, it has demonstrated success in imaging across a wide range of diagnostic applications. OBJECTIVE: To demonstrate, by performing a third ventriculostomy and visualizing the cranial nerves and brainstem anatomy, that, without modification, the SFE can be used through a transcranial approach in a therapeutic intraventricular neurosurgical application. METHODS: A 3.7 French SFE system was used without modification on a live porcine model to perform a third ventriculostomy and acquire high-resolution images of the animal's ventricular system, cranial nerves, and brainstem. A side-by-side comparison was made with one of the current standard-of-care rigid endoscopes as a context for size and image quality. RESULTS: High-resolution video-rate imaging was used to assist the successful, uncomplicated performance of a third ventriculostomy. High-resolution endoscopic images of the brainstem and cranial nerves were acquired. CONCLUSION: Although the SFE has been shown to be a superior device for imaging, here we demonstrate its first use as a potential therapeutic device in intracranial neurosurgery.

11 July 2019 in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Verified
Journal Article
Closed access
PDF file
MKMichelle M. Kameda-Smith
Michelle M. Kameda-Smith
AWAlick Wang
Alick Wang
NANoora Abdulhadi
Noora Abdulhadi
RVRebecca Voth
Rebecca Voth
ASAnjali Sergeant
Anjali Sergeant
OGon behalf of the Pediatric Brain Tumour Study Group
on behalf of the Pediatric Brain Tumour Study Group
Introduction: Children diagnosed with medulloblastoma (MB) who are refractory to upfront therapy or experience recurrence have very poor prognoses. Although phase I and phase II trials exist, these treatments bear significant treatment-related morbidity and mortality. Methods: A retrospective review of children diagnosed with a recurrence of MB from 2002 to 2015 at McMaster University was undertaken. Results: Recurrent disease in 10 patients involved leptomeningeal dissemination, with 3 experiencing local recurrence. In three recurrent patients the disease significantly progressed, and the children were palliated. The remaining 10 children underwent some form of salvage therapy, including surgical re-resection, radiation, and chemotherapy, either in isolation or in varying combinations. Of the 13 children experiencing treatment-refractory or recurrent disease, 4 are currently alive with a median follow-up of 38.5 months (75.5 months). Of the eight patients with molecular subgrouping data, none of the Wnt MB experienced recurrence. Conclusion: Recurrent MB carried a poor prognosis with a 5-year overall survival (OS) of 18.2% despite the administration of salvage therapy. The upfront therapy received, available treatment, and tolerability of the proposed salvage therapy resulted in significant heterogeneity in the treatment of our recurrent cohort. Traitement de sauvetage dans le cas du médulloblastome chez l’enfant : une expérience menée au sein d’un établissement hospitalier. Introduction: Les enfants chez qui l’on a diagnostiqué un médulloblastome réfractaire à un traitement initial ou qui sont victimes d’une récidive présentent d’habitude des pronostics de guérison vraiment défavorables. Bien qu’il existe des traitements basés sur des essais cliniques de phases I et II, ces traitements ont tendance à produire des taux notables de morbidité et de mortalité. Méthodes: Nous avons ainsi mené à l’Université McMaster une analyse rétrospective des dossiers d’enfants chez qui l’on avait diagnostiqué entre 2002 et 2015 une récidive de médulloblastome. Résultats: La réapparition de cette maladie chez 10 patients a provoqué un phénomène de diffusion leptoméningée, trois d’entre eux étant victimes d’une récidive locale. Sur ces 10 jeunes patients, la maladie a progressé de façon importante : ces enfants ont alors été transférés aux soins palliatifs. Quant aux autres 10 enfants, ils ont subi un certain type de traitement de sauvetage (des résections chirurgicales, de la radiothérapie, de la chimiothérapie), que ce soit de façon exclusive ou en variant les combinaisons possibles. Sur les 13 enfants réfractaires à un traitement initial ou victimes d’une récidive, 4 sont toujours en vie, leur suivi médian ayant été de 38,5 mois (75,5 mois). Sur les 8 patients pour qui on a pu obtenir des données moléculaires, aucun de ceux qui étaient atteints d’un médulloblastome du sous-type Wnt n’a connu de récidive. Conclusion: Les médulloblastomes qui réapparaissent après une période de guérison complète présentent un pronostic de guérison défavorable. Leur taux de survie globale est en effet de 18,2 % au cours d’une période de 5 ans, et ce, même après avoir bénéficié d’un traitement de sauvetage. Ajoutons aussi que le type de traitement initial reçu, la disponibilité des traitements ainsi que la tolérance à l’égard des traitements de sauvetage proposés a entraîné une grande hétérogénéité dans le traitement de ces jeunes patients victimes d’une récidive.